shady
Member
i find i have to rub sudocrem cream (nappy rash cream) under my bottom lip or i get a rash that looks like herpes and gets worse after a few nights of rubbing on the silicone. may be an idea to keep some on hand just in case
MESO-Rx
Anabolic Steroids
Sleep ...
- Thread starter FiEnD
- Start date
Damn dude, @DickySmalls in da house. How you been bro?
DickySmalls
Member
What's your leak rate like? If it's really low, it'll help to loosen the mask a bit. Have you used the feature that lets you do a leak test? It may be worth fiddling with that to find out how loose you can get your mask while maintaining low leakage. My "perfect fit" at the start was way too tight.
Yo. Been struggling with the sleep still haha. Makes making progress difficult but I'm hoping this mask will finally get rid of my day time tiredness. Should have told them I wanted a full face mask from day 1.
shady
Member
the mask seal setting always says good fit and it doesnt leak since getting the nose pad, ill try and loosen it slightly. i think its more a leftover from when the mask was a bad fit and wearing it every night since hasnt given the rash time to calm down.
DickySmalls
Member
Full face mask is the way to go after using it for a bit. I'm finally no longer tired during the day. If only I got one from the start....
shady
Member
glad its working well for you . im used to mine now , sleeping well and noticeably stronger in the gym with more energy, most surprising thing is how much easier i find it to focus on day to day tasks. im finding it works better if i put hot(ish) water in the humidifier rather than cold, totally in the routine now and loving it
Obstructive Sleep Apnea and Testosterone Therapy
Introduction There is persistent speculation that testosterone therapy (TTh) may induce worsening of obstructive sleep apnea (OSA). As both the incidence of OSA and the use of TTh grow more prevalent, it is important to review the current evidence that supports or refutes this relationship.
Objectives To review the current literature regarding the relationship between TTh and OSA.
Methods A literature search was conducted to identify relevant studies. Search terms included “obstructive sleep apnea” and “testosterone replacement therapy.” Titles and abstracts were reviewed for relevance. References from identified articles were searched and included, if appropriate.
Results The association between TTh and OSA was initially described in a 1978 case report of an individual with worsened nighttime apneas during testosterone administration, a trend seen again in subsequent small case series.
In the 1990s, a large retrospective analysis and the first randomized controlled trial on the subject revealed no increased incidence of OSA in individuals on TTh. A randomized controlled trial conducted in 2012 provided a possible explanation to the previously reported discrepancies, describing a time-limited effect, wherein measures of OSA were elevated at seven weeks but were not significantly different at 18 weeks after initiation of TTh. A recent cohort study demonstrated an incidence of OSA in individuals on TTh of 16.5% compared with 12.7% in controls. TTh is thought to affect OSA in several ways.
Theories that the anabolic effects of testosterone may decrease airway patency or that testosterone alters sleep architecture have been largely disproven. More likely, testosterone plays a role in altering neural response pathways to hypoxemia.
Conclusions TTh likely plays a small role in exacerbating or inducing changes in OSA that may be time limited in nature. Clinicians may choose to exercise caution in prescribing TTh to individuals suffering from severe OSA.
Payne K, Lipshultz LI, Hotaling JM, Pastuszak AW. Obstructive Sleep Apnea and Testosterone Therapy. Sexual Medicine Reviews 2020. http://www.sciencedirect.com/science/article/pii/S2050052120300408
Introduction There is persistent speculation that testosterone therapy (TTh) may induce worsening of obstructive sleep apnea (OSA). As both the incidence of OSA and the use of TTh grow more prevalent, it is important to review the current evidence that supports or refutes this relationship.
Objectives To review the current literature regarding the relationship between TTh and OSA.
Methods A literature search was conducted to identify relevant studies. Search terms included “obstructive sleep apnea” and “testosterone replacement therapy.” Titles and abstracts were reviewed for relevance. References from identified articles were searched and included, if appropriate.
Results The association between TTh and OSA was initially described in a 1978 case report of an individual with worsened nighttime apneas during testosterone administration, a trend seen again in subsequent small case series.
In the 1990s, a large retrospective analysis and the first randomized controlled trial on the subject revealed no increased incidence of OSA in individuals on TTh. A randomized controlled trial conducted in 2012 provided a possible explanation to the previously reported discrepancies, describing a time-limited effect, wherein measures of OSA were elevated at seven weeks but were not significantly different at 18 weeks after initiation of TTh. A recent cohort study demonstrated an incidence of OSA in individuals on TTh of 16.5% compared with 12.7% in controls. TTh is thought to affect OSA in several ways.
Theories that the anabolic effects of testosterone may decrease airway patency or that testosterone alters sleep architecture have been largely disproven. More likely, testosterone plays a role in altering neural response pathways to hypoxemia.
Conclusions TTh likely plays a small role in exacerbating or inducing changes in OSA that may be time limited in nature. Clinicians may choose to exercise caution in prescribing TTh to individuals suffering from severe OSA.
Payne K, Lipshultz LI, Hotaling JM, Pastuszak AW. Obstructive Sleep Apnea and Testosterone Therapy. Sexual Medicine Reviews 2020. http://www.sciencedirect.com/science/article/pii/S2050052120300408
